Drugs / Diphtheria,Tetanus and Acellular Pertussis Combined Vaccine, Adsorbed
Diphtheria,Tetanus and Acellular Pertussis Combined Vaccine, Adsorbed
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT05091619 Comparator | Oct 2021 → Jan 2024 overdue | diphtheria, pertussis, tetanus | China National Biotec Group Company Limited | Active not recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Diphtheria,Tetanus and Acellular Pertussis Combined Vaccine, Adsorbed | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05091619 ↗ |
| Modality | Vaccine | “Combined Vaccine” NCT05091619 ↗ |
| Route | Intramuscular | “Intramuscular injection” NCT05091619 ↗ |